These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26007164)

  • 21. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.
    Pu Y; Li S; Zhang C; Bao Z; Yang Z; Sun L
    J Neurooncol; 2015 Mar; 122(1):43-51. PubMed ID: 25527046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups.
    Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL
    Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
    Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC
    Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
    Field KM; Phal PM; Fitt G; Goh C; Nowak AK; Rosenthal MA; Simes J; Barnes EH; Sawkins K; Cher LM; Hovey EJ; Wheeler H
    Cancer; 2017 Sep; 123(18):3576-3582. PubMed ID: 28678383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
    Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
    Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
    Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
    Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape.
    Holmberg Olausson K; Elsir T; Moazemi Goudarzi K; Nistér M; Lindström MS
    Sci Rep; 2015 Nov; 5():16495. PubMed ID: 26559910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of c-Met is associated with poor prognosis in glioblastoma.
    Petterson SA; Dahlrot RH; Hermansen SK; K A Munthe S; Gundesen MT; Wohlleben H; Rasmussen T; Beier CP; Hansen S; Kristensen BW
    J Neurooncol; 2015 May; 122(3):517-27. PubMed ID: 25800004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
    Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
    Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
    Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
    Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of CDC25B expression in gliomas.
    Nakabayashi H; Hara M; Shimizu K
    J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oct-3/4 promotes migration and invasion of glioblastoma cells.
    Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
    J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.